Benzinga | Mar 2, 2021 10:37AM EST

Immatics Granted U.S. Patent Titled 'Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers'

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10934339.PN.&OS=PN/10934339&RS=PN/10934339